We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
UK Standards for Microbiology Investigations (SMI) B 19: Investigation of sinus aspirate.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
The Terrorism Act 2000 video recording code of practice was updated in Northern Ireland in 2020
This report (HPA-CRCE-031) is a compilation of data on extra-thoracic (ET) retention and clearance from a human study of nasal clearance.
Product safety report for HQ Products Pop Up Tent - 2 person, presenting a serious risk of burns & suffocation
This is a review of entitlement to Industrial Injuries Disablement Benefit for people with nasal carcinoma and occupational exposure to wood dust.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Omega Pharma Ltd has identified that there is text missing in Section 2 of the Patient Information Leaflet (PIL) in packs of Beconase Hayfever Nasal Spray (P).
This analysis examines the impacts on a person’s chances of finding a job following a stint out of work, using quarterly data from the Labour Force Survey and annual data from Understanding Society.
AstraZeneca UK Ltd. has informed the MHRA of an issue related to the expiry dates for certain batches of Fluenz Tetra. This recall provides further advice on the safe use of the product up to the amended expiry date.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.